KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) FCF Margin (2017 - 2025)

Guardant Health (GH) has disclosed FCF Margin for 9 consecutive years, with 19.28% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 654.0% to 19.28% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 23.73% through Dec 2025, up 924.0% year-over-year, with the annual reading at 23.73% for FY2025, 924.0% up from the prior year.
  • FCF Margin hit 19.28% in Q4 2025 for Guardant Health, down from 17.26% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 17.26% in Q3 2025 to a low of 123.66% in Q2 2022.
  • Historically, FCF Margin has averaged 49.81% across 5 years, with a median of 43.2% in 2022.
  • Biggest YoY gain for FCF Margin was 8351bps in 2021; the steepest drop was -8907bps in 2021.
  • Year by year, FCF Margin stood at 32.81% in 2021, then grew by 24bps to 24.89% in 2022, then plummeted by -115bps to 53.4% in 2023, then skyrocketed by 52bps to 25.82% in 2024, then increased by 25bps to 19.28% in 2025.
  • Business Quant data shows FCF Margin for GH at 19.28% in Q4 2025, 17.26% in Q3 2025, and 28.41% in Q2 2025.